NDST3‐Induced Epigenetic Reprogramming Reverses Neurodegeneration in Parkinson's Disease
Advanced Science · 2026
DOI: 10.1002/advs.202507323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yujung Chang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Regenerative Medicine for Neurodegenerative Disease, Stand Up Therapeutics Inc., Hannamdaero 98, Seoul, 04418, South Korea. Hauptthemen laut MEDLINE: Parkinson Disease, Epigenesis, Genetic. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bio & Medical Technology Development Program of the National Research Foundation, Institute for Basic Science, Korean government.
Abstract (Originalsprache)
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons (DN) in the substantia nigra and disruption of cellular maintenance. Here, we demonstrate that NDST3‐mediated epigenetic reprogramming halts neuronal degeneration and restores motor function in an animal model of PD. Following NDST3 administration, the DN and its associated circuits in the substantia nigra and striatum showed marked revitalization, accompanied by a considerable alleviation of PD‐like motor deficits. Integrative single‐cell and spatial RNA sequencing with CUT&RUN revealed that NDST3‐driven reactivation of pathways is linked to neuronal survival, synaptic integrity, and steering of compromised cells toward a resilient phenotype. By recalibrating the epigenetic landscape, NDST3 promotes cellular maintenance and functional recovery in key motor circuits. These findings highlight NDST3's therapeutic potential as an epigenetic modulator of PD. These findings provide insights into the mechanisms underlying neuronal revitalization and highlight the potential of NDST3 as a novel agent for restoring brain function in neurodegenerative conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Regenerative Medicine for Neurodegenerative Disease, Stand Up Therapeutics Inc., Hannamdaero 98, Seoul, 04418, South Korea.
- Center for RNA Research, Institute for Basic Science, Seoul, 08826, South Korea.
- School of Biological Sciences, Seoul National University, Seoul, 08826, South Korea.
- Department of Anatomy, College of Medicine, Korea University, Seoul, 02841, South Korea.
- Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, South Korea.
- Biology Department, Boston University, Boston, MA, 02215, USA.
ORCID-Profile: Jong-Seo Kim, Junsang Yoo
Förderung
- Bio & Medical Technology Development Program of the National Research Foundation
- Institute for Basic Science
- Korean government
Zitieren
APA
Chang, Y., Na, Y., Im, H., Yang, G., Yang, S., Shim, H. S., Kim, C., Kim, G., Park, H. J., Kim, H. Y., Lee, S. E., Lee, W., Ha, Y., Park, S., Kim, J., Cho, W. Y., Sun, W., Kim, J. S., & Yoo, J. (2026). NDST3‐Induced Epigenetic Reprogramming Reverses Neurodegeneration in Parkinson's Disease. Advanced Science. https://doi.org/10.1002/advs.202507323
Vancouver
Chang Y, Na Y, Im H, Yang G, Yang S, Shim HS, et al. NDST3‐Induced Epigenetic Reprogramming Reverses Neurodegeneration in Parkinson's Disease. Advanced Science. 2026. doi:10.1002/advs.202507323
BibTeX
@article{Chang2026,
author = {Chang, Yujung and Na, Yongwoo and Im, Hyeonjoo and Yang, Garam and Yang, Seungseon and Shim, Hyun Soo and Kim, Chunggoo and Kim, GyeungYun and Park, Hyeok Ju and Kim, Hee Young and Lee, Seung Eun and Lee, Wonwoong and Ha, Yoon and Park, Sungho and Kim, Jieun and Cho, Won-Young and Sun, Woong and Kim, Jong-Seo and Yoo, Junsang},
title = {NDST3‐Induced Epigenetic Reprogramming Reverses Neurodegeneration in Parkinson's Disease},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202507323}
}
EUVIMED